Serum 25-hydroxyvitamin D is not associated with insulin resistance or beta cell function in Canadian Cree

Journal of Nutrition

Volumn 141, Issue 2, 2011, Pages 290-295

  Del Gobbo, Liana C ^a   Song, Yiqing ^b   Dannenbaum, David A ^c,d   Dewailly, Eric ^e   Egeland, Grace M ^a  

^a MCGILL UNIVERSITY   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Cree Board of Health and Social Services of James Bay   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; GLUCOSE; INSULIN;

ADULT; AGE; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BODY MASS; CANADA; EDUCATIONAL STATUS; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PHYSICAL ACTIVITY; SEX DIFFERENCE; SMOKING; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; OBESITY; QUEBEC; RISK; VITAMIN D;

EID: 79251490394     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.110.129619     Document Type: Article

References (31)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53.
2. Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao XJ, Logan A, Zinman B. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care. 1997;20:185-7.
3. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care. 2006;29:2114-6.
4. Dannenbaum D, Kuzmina E, Lejeune P, Torrie J, Gangbe M. Prevalence of diabetes and diabetes-related complications in First Nations communities in northern Quebec (Eeyou Istchee), Canada. Can J Diabetes. 2008;32:46-52.
5. Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79:820-5.
6. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. Review: the role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis. J Clin Endocrinol Metab. 2007;92:2017-29.
7. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10:185-97.
8. Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D-3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med. 2009;26:19-27.
9. Lu L, Yu ZJ, Pan A, Hu FB, Franco OH, Li HX, Li XY, Yang XL, Chen Y, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009;32:1278-83.
10. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely Prospective Study 1990-2000. Diabetes. 2008;57:2619-25.
11. Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, Perkins BA, Harris SB, Zinman B, et al. Association of vitamin D with insulin resistance and beta cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010;33:1379-81.
12. Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, Booth SL, Jacques PF. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009;139:329-34.
13. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27:2813-8.
14. Zhao G, Ford ES, Li CY. Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among US adults without physician-diagnosed diabetes: NHANES, 2003-2006. Diabetes Care. 2010;33:344-7.
15. Moffatt ME. Current status of nutritional deficiencies in Canadian aboriginal people. Can J Physiol Pharmacol. 1995;73:754-8.
16. Downs SM, Arnold A, Marshall D, McCargar LJ, Raine KD, Willows ND. Associations among the food environment, diet quality and weight status in Cree children in Quebec. Public Health Nutr. 2009;12:1504-11.
17. Bonora E, Saggiani F, Targher G, Zenere MB, Alberiche M, Monauni T, Bonadonna RC, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57-63.
18. Song Y, Manson JE, Tinker L, Howard BV, Kuller LH, Nathan L, Rifai N, Liu SM. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: The Women's Health Initiative Observational Study. Diabetes Care. 2007;30:1747-52.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
20. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18-28.
21. Flegal KM, Carrol MD, Ogden CL, Curtin LB. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235-41.
22. Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int. 2007;71:134-9.
23. Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J, Saltzman E, Dawson-Hughes B. Vitamin D-3 in fat tissue. Endocr. J. 2008;33:90-4.
24. Engelsen O, Brustad M, Aksnes L, Lund E. Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness. Photochem Photobiol. 2005;81:1287-90.
25. Cosman F, Morgan DC, Nieves JW, Shen V, Luckey MM, Dempster DW, Lindsay R, Parisien M. Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res. 1997;12:958-66.
26. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest. 1985;76:470-3.
27. Bodnar LM, Simhan HN, Powers RW, Frank MP, Cooperstein E, Roberts JM. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr. 2007;137:447-52.
28. Weiler HA, Leslie WD, Krahn J, Steiman PW, Merge CJ. Canadian aboriginal women have a higher prevalence of vitamin D deficiency than non-aboriginal women despite similar dietary vitamin D intakes. J Nutr. 2007;137:461-5.
29. Larcombe LA, Orr PH, Lodge AM, Brown JS, Dembinski IJ, Milligan LC, Larcombe EA, Martin BD, Nickerson PW. Functional gene polymorphisms in Canadian Aboriginal populations with high rates of tuberculosis. J Infect Dis. 2008;198:1175-9.
30. Lee P, Greenfield JR, Seibel MJ, Eisman JA, Center JR. Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med. 2009;122:1056-60.
31. Aloia JF, Patel M, DiMaano R, Li-Ng M, Talwar SA, Mikhail M, Pollack Sand S, Yeh JK. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr. 2008;87:1952-8.